Jill Feldman: Submit your abstract for the EGFR Resisters Research Summit
EGFR Resisters Research Summit shared a post on X:
”Have you submitted your abstract for EGFR Summit?
Deadline is September 30 – boost your career as a lung cancer researcher! Submit abstracts.”
Jill Feldman shared a post by EGFR Resisters Research Summit, on X, adding:
”It’s that time! Submit your abstract for the EGFR Resisters Research Summit!
Great opportunity to network with thought leaders in lung cancer, other early career investigators, and of course, a few advocates.
The deadline to submit abstracts is September 30th. You can submit them here.”
Source: EGFR Resisters Research Summit/X and Jill Feldman/X
Jill Feldman is a lung cancer patient and advocate. She is the Co-Founder EGFR Resisters, an advocacy group of EGFR positive lung cancer patients who are resistant to targeted treatment. She is the Past President of the LUNGevity Foundation, Deputy Chair of IASLC’s patient advisory board and a member of The Chicago Institute of Translational Medicine’s patient advisory board. Jill is a member of the programmatic panel for the Department of Defense Lung Cancer Research Program, a planning committee member on IASLC’s North America Conference on Lung cancer and as a member of the the ECOG-ACRIN Research Group’s patient advocate committee and thoracic committee.